Structure and function of angiotensin converting enzyme and its inhibitors

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 24, Issue 2, 2008, Pages 171-176

  Zhao, Yulan ^a   Xu, Chuanlian ^a  

^a ZHEJIANG SCI TECH UNIVERSITY   (China)

Author keywords

Agiotensin converting enzyme; Gene polymorphism; Inhibitor; Structure and function

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CHEMISTRY; GENETIC POLYMORPHISM; GENETICS; HUMAN; METABOLISM; STRUCTURE ACTIVITY RELATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; HUMANS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 40349087155     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1872-2075(08)60007-2     Document Type: Review

References (29)

1. De Mello WC. Angiotensin converting enzyme and the arrhythmogenic action of angiotensin I: Cardiac cell membrane as a site of angiotensin I conversion. Regulatory Peptides, 2004, 121: 83-88.
2. Coates D. The angiotensin converting enzyme (ACE). International Journal of Biochemistry and Cell Biology, 2003, 35: 769-773.
3. Hubert C, Houot AM, Corvol P, et al. Sructure of the angiotensin I-converting enzyme gene: Two alternate promoters correspond to evolutionary steps of a duplicated gene. Journal of Biological Chemistry, 1991, 266: 15377-15383.
4. Thekkumkara TJ, LivingstonIII WS, Kumar RC, et al. Use of alternative polyadenylation sites for tissue-specific transcription of two angiotensin-converting enzyme mRNAs. Nucleic Acids Research, 1992, 20 (4): 683-687.
5. Ehlers MRW, Fox EA, Strydom DJ, et al. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proceedings of the National Academy of Sciences of the United States of America, 1989, 86: 774-7745.
6. Kumar RS, Kusari J, RoyQII SN, et al. Structure of testicular angiotensin-converting enzyme. Journal of Biological Chemistry, 1989, 264 (28): 16754-16758.
7. Riordan JF. Angiotensin-I-converting enzyme and its relatives. Genome Biology; 2003; 4 (8): 225.
8. Hu JG, Igarashi A, Kamata M, Nakagawa H. Angiotensin-converting enzyme degrades Alzheimer Amyloid β-Peptide (A β), rerards A β aggregation, deposition, fibril formation, and inhibits cytotoxicity. Journal of Biological Chemistry, 2001, 276 (51): 47863-47868.
9. Kondoh G, Tojo H, Nakatani Y, et al. Angiotensin-converting enzyme is a GPI-anchored protein releasing factor crucial for fertilization. Nature Medicine, 2005, 11: 160-166.
10. Morshed M, Khan H. Akhteruzzaman S. Association between Angiotensin I-converting enzyme gene polymorphism and hypertension in selected individuals of the Bangladeshi population. Journal of Biochemistry and Molecular Biology, 2002, 35: 25-254.
11. Agachan B, Isbir T, Yilmaz H, et al. Angiotensin converting enzyme I/D, Angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Experimental and Molecular medicine, 2003, 35 (6): 545-549.
12. Ohira N, Matsumoto T, Tamaki S, et al. Angiotensinconverting enzyme insertion/deletion polymorphism modulates coronary release of tissue plasminogen activator in response to bradykinin. Hypertens Research, 2004, 27 (1): 39-45.
13. Iwai N, Tamaki S, Ohmichi N, et al. The II genotype of the angiotensin-converting enzyme gene delays the ouset of acute coronary syndromes. Arterioscler Thromb Basc Biol, 1997, 17: 1730-1733.
14. Tipnis SR, Hooper NM, Hyde R, et al. A human homolog of angiotensin-converting enzyme. Journal of Biological Chemistry, 2000, 275 (43): 33238-33243.
15. Guo XQ, Mit K, Okano K, et al. Isolation and expression of the ecdysteroid-inducible angiotensin-converting enzyme-related gene in wing discs of Bombyx mori. Insect Biochemistry and Molecular Biology, 2001, 31: 97-103.
16. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotenin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensinIto angiotensin1-9. Circulation research, 2000, 87: 1-9.
17. Rice GI, Thomas DA, Grant PJ, et al. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J, 2004, 383: 45-51.
18. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 2003, 426 (6965): 450-454.
19. Lang AD, Osterhqus ADME, Haagmans BL. Interferon-γ and interlwukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells. Virology, 2006, 6 (11): 1-8.
20. Ho TY, Wu SL, Chen JC, et al. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antivirl Research, 2006, 2103: 1-10.
21. Bicket DP. Using ACE inhibitors appropriately. American Family Physician, 2002, 66: 461-468
22. Pagliaro P, Penna C. Rethinking the rennin-angiotensin system and its role in cardiovascular regulation. Cardiovascular Drugs and Therapy, 2005, 19: 1977-1987.
23. Pitt B. ACE inhibitors in heart failure: Prospects and limitations. Cardiovascular Drugs and Therapy, 1997, 11: 285-290.
24. De Gusmao FMB, Becker C, Carvalho MHC, et al. Angiotensin II inhibition during myocardial ischemia-reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity. International Journal of Cardiology, 2005, 100: 363-370.
25. Francis J, Shun GW, Weiss MR, et al. Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. American Journal of Physiology-Heart and Circulatory Physiology, 2004, 287: 2138-2146.
26. Georgiadis D, Beau F, Czarny B, et al. Roles of two sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: Insight from selective inhibitors. Circulation research, 2003, 93: 148-154.
27. Van Esch JHM, Tom B, Dive V, et al. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction. Hypertension, 2005, 45: 120-125.
28. Junot C, Gonzales MF, Ezan E, et al. A selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis. The Journal of Pharmacology and Experimental Therapeutics, 2001, 297: 606-611.
29. Dive V, Cotton J, Yiotakis A, et al. RXP407, a phpsphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites. Proceedings of the National Academy of Sciences of the United States of America. 1999, 96: 4330-4335.